Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer

(1) Background: There are currently limited treatments for castration-resistant prostate cancer. Immunotherapy involving Sipuleucel-T has increasingly drawn attention for prostate cancer management. BCG plays a vital role in treating bladder cancer, mainly by inducing immune activation, but is rarel...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Linpei, Xie, Hui, Zhang, Zheng, Wang, Zhun, Peng, Shuanghe, Niu, Yuanjie, Shang, Zhiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310044/
https://www.ncbi.nlm.nih.gov/pubmed/34358202
http://dx.doi.org/10.3390/vaccines9070786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310044/
https://www.ncbi.nlm.nih.gov/pubmed/34358202
http://dx.doi.org/10.3390/vaccines9070786

Ejemplares similares